| 【Company Research】Tongcheng-Elong (780 HK) – Solid recovery ahead |
| 【Company Research】Kintor Pharmaceutical (9939 HK) – Specializing in AR-related innovative therapies |
| 【公司研究】比亞迪控股 - A (002594 CH) – 深藏若虛,漸露鋒芒 |
| 【公司研究】比亞迪控股 - H (1211 HK) – 深藏若虛,漸露鋒芒 |
| 【Company Research】Wisdom Education (6068 HK) – Tuition fees increase beat; lift TP to HK$6.38 |
| 【Company Research】AAC (2018 HK) – Strategic investors to boost synergy and unlock value; Upgrade to HOLD on fair valuation |
| 【公司研究】雅生活 (3319 HK) – 上半年盈喜;開啟新業務 |
| 【Company Research】CICC (3908 HK) – Raises A-share IPO size; mega deals to help with ROE recovery |
| 【Company Research】Alibaba (9988 HK) – More catalysts to come |
| 【Company Research】Alibaba (BABA US) – More catalysts to come |